Infosys, L&T, BPCL: Top Picks for March 24 Trading as Market Eyes Rebound

STOCK-INVESTMENT-IDEAS
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Infosys, L&T, BPCL: Top Picks for March 24 Trading as Market Eyes Rebound
Overview

Indian equity markets look set for a rebound on March 24, buoyed by hopes of easing geopolitical tensions. Analysts have identified 11 key trading ideas, spotlighting Infosys, Larsen & Toubro, Bharat Petroleum Corporation, and Aurobindo Pharma. The outlook considers technical indicators and potential short-covering rallies following recent market dips.

Indian Markets Poised for Rebound on March 24

Indian stocks are set for a potential rebound on March 24 after the Nifty 50 dropped 2.6% on March 23 amid global weakness. Hopes for easing geopolitical tensions are boosting sentiment. Experts are highlighting specific stocks expected to benefit from short-covering rallies and technical breakouts.

Infosys: A Key Pick Amid Tech Strength

Infosys has shown strong resilience, holding steady even as the broader market fell. This stability is a positive indicator. With significant short positions built up, the stock could see a short-covering rally. Experts suggest buying Infosys Futures between Rs 1,240–1,250, aiming for Rs 1,320–1,350, with a stop-loss at Rs 1,210.

BPCL and PFC: Energy Sector Focus

Bharat Petroleum Corporation (BPCL) is also eyed for a short-term bounce. High crude oil prices and geopolitical tensions led to significant short positions and pushed the Put-Call Ratio (PCR) to oversold levels. With monthly settlements near and potential drops in international crude prices, a short-covering rally is expected. Buying BPCL Futures between Rs 270–273 is suggested, with a target of Rs 285–295 and a stop-loss at Rs 264. Power Finance Corporation (PFC) shows strong structural development and relative strength, breaking out from a flag-and-pole pattern. Buying is recommended at Rs 335–340, targeting Rs 426, with a stop-loss at Rs 382.

Aurobindo Pharma and L&T: Pharma and Infrastructure Plays

Aurobindo Pharma has achieved a significant technical breakout after weeks of consolidation, indicating a likely return to upward momentum. Positive indicators include a DMI with a positive bias, RSI above 60, and a bullish MACD crossover, all confirming increased buying interest. Traders are advised to buy in the Rs 1,260–1,280 range, targeting Rs 1,390, with a stop-loss at Rs 1,235. Larsen & Toubro (L&T), despite recent drops, shows weakening selling momentum. The RSI is not making new lows, and the MACD is in oversold territory, suggesting a potential technical pullback. A buy recommendation is made for Rs 3,350–3,350, targeting Rs 3,600, with a stop-loss at Rs 3,250.

Power Grid and Prime Focus: Infrastructure and Manufacturing

Power Grid Corporation of India has resumed its uptrend after breaking out of a pennant triangular pattern, showing strong relative strength. The MACD indicator is above its equilibrium line. A buy strategy is recommended, targeting Rs 332 with a stop-loss of Rs 290. Prime Focus is maintaining a higher high-higher low structure and staying above key EMAs. It shows bullish recovery towards its 50-day moving average (DEMA), with the MACD reflecting sustained positive momentum. A target of Rs 325 is set, with a stop-loss at Rs 272.

Stocks Facing Potential Declines: Sell Picks

Not all stocks are showing positive signs. NMDC has broken below a two-month consolidation range and its 200-day moving average (DMA), indicating a potential correction. Selling March Futures between Rs 76–76.60 is advised, targeting Rs 72–70, with a stop-loss at Rs 80. Adani Green Energy has also broken down from a bearish flag pattern. Daily momentum indicators show a bearish crossover, suggesting the downtrend will continue. Selling March Futures between Rs 830–837 is recommended, targeting Rs 785–765, with a stop-loss at Rs 870. Crompton Greaves Consumer Electricals has also broken down from a flag pattern and is trading below key averages, signaling a bearish trend continuation. Sell March Futures between Rs 238–239, targeting Rs 220–215, with a stop-loss at Rs 248.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.